对《奥地利芦可替尼治疗骨髓纤维化：治疗管理共识》的勘误
Correction to: Ruxolitinib therapy formyelofibrosis in Austria : Consensus on therapy management.
作者信息
Krauth Maria-Theresa, Burgstaller Sonja, Buxhofer-Ausch Veronika, Gastl Günther, Geissler Klaus, Keil Felix, Krippl Peter, Melchardt Thomas, Petzer Andreas, Rumpold Holger, Sliwa Thamer, Wöhrer Stefan, Wölfler Albert, Gisslinger Heinz
机构信息
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University Vienna, Vienna, Austria.
Department of Internal Medicine IV, Klinikum Wels-Grieskirchen, Wels, Austria.
出版信息
Wien Klin Wochenschr. 2019 Jan;131(1-2):47. doi: 10.1007/s00508-018-1428-7.
Correction to:Wien Klin Wochenschr 2018 https://doi.org/10.1007/s00508-018-1365-5 The original version of this article unfortunately contained a mistake. Table Nr. 1 was inconsistent. The corrected version of Table 1 is given below. We apologize for any inconveniences this may have ….
对以下文献的勘误
《维也纳临床周报》2018年https://doi.org/10.1007/s00508-018-1365-5 很遗憾，本文的原始版本存在一个错误。表1不一致。下面给出表1的更正版本。对于由此可能带来的任何不便，我们深表歉意。
Zotero 插件